Ibrutinib

Min.Order / FOB Price:Get Latest Price

1 Gram	Negotiable

1 Gram

Negotiable

Min.Order :1 Gram
Purity: 95%

Keywords

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-on PCI-32765 selective Btk inhibitor

Quick Details

Appearance:white powder
Application:Ibrutinib shows the potent and irreversible inhibitory effect and selectivity for Btk enzymatic activity. In BCR pathway-activated DOHH2 cell line, Ibrutinib inhibits autophosphorylation of Btk, phosp
PackAge:
ProductionCapacity:|Metric Ton|Day
Storage:2 years -20°CPowder 6 months-80°Cin DMSO
Transportation:

Superiority:

High Quality

Details:

Ibrutinib shows the potent irreversible inhibitory effectivity fBtk enzymatic activity. In BCR pathway-activated DOHH2 cell line, Ibrutinib inhibits autophosphorylation of Btk, phosphorylation of Btk's physiological substrate PLCγ, phosphorylation of further downstream kinase, ERK with IC50 of 11 nM, 29 nM 13 nM, respectively. ^[1] Ibrutinib exhibits a significant dose-dependent time-dependent induction of cytotoxicity inonic lymphocytic leukemia (CLL) cells. In addition, Ibrutinib induces cell death depending on caspase pathway activation antagonizes the ability of CLL cells to proliferate after TLR signaling. ^[2] A recent study shows that Ibrutinib inhibits BCR-activated primary B cell proliferation with IC50 of 8 nM results in inhibition of TNFα, IL-1β IL-6 production in primary monocytes with IC50 of 2.6 nM, 0.5 nM 3.9 nM, respectively. ^[3]

View All